Peroxisome Proliferator-Activated Receptors as New Molecular Targets in Psoriasis

E-ISSN： 1875-5933|3|2|205-211

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.3, Iss.2, 2004-06, pp. : 205-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator-activated receptors as molecular targets in relation to obesity and Type 2 diabetes

By ŠŠeda Ondøøřřej ŠŠedováá Lucie

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 587-596

Future Medicine

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptors and the Control of Inflammation Update

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 297-298

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator activated receptors and obesity

By Kersten S.

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 223-234

Elsevier

Access to resources Recommend Favorite

Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury

By Esposito Emanuela Cuzzocrea Salvatore

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 8, 2011-08 ,pp. : 943-959

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury

By Paola Rosanna Cuzzocrea Salvatore

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 3, 2007-05 ,pp. : 157-175

Springer Publishing Company

Access to resources Recommend Favorite